<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="49200">Proton-pump inhibitors</z:chebi> are effective at preventing the acid component of gastro-oesophageal refluxate from entering the oesophagus </plain></SENT>
<SENT sid="1" pm="."><plain>It is not clear whether <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> prevent duodenogastro-<z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">oesophageal reflux</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To measure oesophageal exposure to duodenogastro-oesophageal refluxate while on <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> in patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Twenty-five patients (23 male) with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> underwent 24 h oesophageal pH and Bilitec 2000 monitoring while on <z:chebi fb="14" ids="7772">omeprazole</z:chebi> 40 mg/day (n = 19) or <z:chebi fb="14" ids="7772">omeprazole</z:chebi> 60 mg/day (n = 6) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were undergoing <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma ablation of their Barrett's epithelium as part of a clinical trial and the Bilitec measurements were only carried out after the ablation had been completed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: 20 of 25 (80%) patients had a <z:mpath ids='MPATH_458'>normal</z:mpath> oesophageal pH profile </plain></SENT>
<SENT sid="6" pm="."><plain>Fifteen of the 25 (60%) had abnormal oesophageal exposure to bile as measured by Bilitec 2000 </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 20 patients who had a <z:mpath ids='MPATH_458'>normal</z:mpath> 24 h oesophageal pH profile, 11 (55%) had pathological exposure to bile in their oesophagus </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Complete acid suppression does not guarantee elimination of duodenogastro-<z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">oesophageal reflux</z:e> </plain></SENT>
</text></document>